Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC spermicides with nonoxynol-9 doses below 100 mg may be "safest choice," FDA told.

This article was originally published in The Tan Sheet

Executive Summary

OTC SPERMICIDES WITH NONOXYNOL-9 DOSES BELOW 100 MG MAY BE "SAFEST CHOICE" for consumers, Columbia Labs states in March 3 comments to FDA. Due to the possible link between vaginal irritation caused by nonoxynol-9 and the spread of sexually transmitted diseases, the company said it believes "it would be a grave error to eliminate from the monograph nonoxynol-9 products with doses lower than 100 mg, because those products, if effective, may represent the safest choice for consumers."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086815

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel